Is MEDS or JEPQ a better dividend investment in 2026?

MEDS currently yields 125.16% with a 5% 5-year dividend growth rate. JEPQ yields 11.10% with 5% growth. The better choice depends on your goal: MEDS offers higher current income.

What is the dividend yield difference between MEDS and JEPQ?

MEDS has a forward dividend yield of 125.16% ($9.50/share annually). JEPQ yields 11.10% ($6.16/share annually). The yield gap is 114.06 percentage points.

Home › Compare › MEDS vs JEPQ

MEDS vs JEPQ: Dividend Comparison 2026

MEDS yields 125.16% · JEPQ yields 11.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MEDS wins by $10.32M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MEDS

● Live price

125.16%

Share price

$7.59

Annual div

$9.50

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$10.37M

Annual income

$4,031,270.48

Full MEDS calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.10%

Share price

$55.52

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.8K

Annual income

$2,152.59

Full JEPQ calculator →

Portfolio growth — MEDS vs JEPQ

📍 MEDS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MEDS	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MEDS + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MEDS pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEDS

Annual income on $10K today (after 15% tax)

$10,639.00/yr

After 10yr DRIP, annual income (after tax)

$3,426,579.91/yr

JEPQ

Annual income on $10K today (after 15% tax)

$943.83/yr

After 10yr DRIP, annual income (after tax)

$1,829.70/yr

At 15% tax rate, MEDS beats the other by $3,424,750.21/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEDS + JEPQ for your $10,000?

MEDS: 50%JEPQ: 50%

100% JEPQ50/50100% MEDS

Portfolio after 10yr

$5.21M

Annual income

$2,016,711.53/yr

Blended yield

38.74%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MEDS right now

MEDS

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-3.0

Piotroski

5/9

JEPQ

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEDS buys

JEPQ buys

No recent congressional trades found for MEDS or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMEDSJEPQ

Forward yield	125.16% ✓	11.10%
Annual dividend / share	$9.50 ✓	$6.16
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$10.37M	$44.8K ✓
Annual income after 10y	$4,031,270.48 ✓	$2,152.59
Total dividends collected	$9.46M	$16.3K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: MEDS vs JEPQ ($10,000, DRIP)

Year	MEDS Portfolio	MEDS Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$23,216	$12,516.47	$11,930	$1,110.39	+$11.3K → MEDS
2	$51,999	$27,157.78	$14,133	$1,224.34	+$37.9K → MEDS
3	$112,487	$56,847.66	$16,632	$1,340.46	+$95.9K → MEDS
4	$235,291	$114,929.87	$19,454	$1,457.97	+$215.8K → MEDS
5	$476,435	$224,673.57	$22,626	$1,576.08	+$453.8K → MEDS
6	$934,959	$425,173.83	$26,175	$1,694.09	+$908.8K → MEDS
7	$1,780,186	$779,779.50	$30,133	$1,811.32	+$1.75M → MEDS
8	$3,292,387	$1,387,588.61	$34,531	$1,927.17	+$3.26M → MEDS
9	$5,921,260	$2,398,405.13	$39,403	$2,041.08	+$5.88M → MEDS
10	$10,367,018	$4,031,270.48	$44,787	$2,152.59	+$10.32M → MEDS

MEDS vs JEPQ: Complete Analysis 2026

MEDS — Stock

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.

Full MEDS Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this MEDS vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEDS vs SCHD MEDS vs JEPI MEDS vs O MEDS vs KO MEDS vs MAIN MEDS vs XYLD MEDS vs QYLD MEDS vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.